Targeted EHR-based Communication of Diagnostic Uncertainty in the ED
TECU
1 other identifier
interventional
300
1 country
1
Brief Summary
The goal of the clinical trial is to evaluate the preliminary effectiveness and the implementation feasibility of the Targeted EHR-based Communication about Uncertainty (TECU) strategy in improving the quality of care transitions from the emergency department (ED) to home. The overall specific aims related to the trial are to test the preliminary effectiveness of TECU compared to standard of care in reducing patient uncertainty and return ED visits and evaluate the adoption of TECU, exploring patient and clinician barriers and facilitators to TECU implementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
November 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
April 16, 2025
April 1, 2025
2 years
February 7, 2024
April 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Uncertainty Scale (U-Scale)
The Uncertainty Scale (U-Scale) is a 30-item scale designed to measure patient-level uncertainty related to acute symptoms independent of underlying disease. The scale uses a 5-point Likert-style response format, asking respondents to indicate agreement with each statement from "strongly disagree" (1) to "strongly agree" (5) and leading to a nominal score range of 30-150. Higher scores indicate greater uncertainty.
enrollment
Secondary Outcomes (3)
The Care Transition Measure (CTM)-3
2 days post enrollment
Transitions During Uncertainty (TDU) questionnaire
2 days post enrollment
Normalisation MeAsure Development questionnaire (NoMAD)
At clinician enrollment
Other Outcomes (15)
Return emergency department (ED) visits
9 days post enrollment
Return emergency department (ED) visits
30 days post enrollment
Composite healthcare utilization
30 days post enrollment
- +12 more other outcomes
Study Arms (2)
Pre-TECU Implementation
NO INTERVENTIONNo intervention administered.
Post-TECU Implementation
EXPERIMENTALWhen an ED clinician enters an uncertain diagnosis for a patient being discharged, the TECU BPA will notify the clinician to counsel the patient about uncertainty while additionally triggering automated 1) insertion and printing of the patient handout and 2) provision of a hyperlink for the clinician-facing checklist to guide the discharge conversation.
Interventions
The Targeted EHR-based Communication about Uncertainty (TECU) strategy will be activated in the electronic health record (Epic) every time an ED clinician enters an uncertain diagnosis for a patient being discharged, and will notify the clinician to counsel the patient about uncertainty while additionally triggering automated 1) insertion and printing of the patient handout and 2) provision of a hyperlink for the clinician-facing checklist to guide the discharge conversation.
Eligibility Criteria
You may qualify if:
- age 18 years or older
- English language speaking
- assigned a symptom-based diagnosis in the EHR clinical impression
- planned for discharge from the ED during the enrollment visit
- able to complete follow up assessments in 2 and 30 days
- TECU best practice advisory (BPA) electronic health record alert activates during their discharge process
You may not qualify if:
- under the age of 18 years
- non-English speaking
- clinically unstable, psychologically impaired or intoxicated, or otherwise unable to provide informed consent as judged by research staff member
- admitted to hospital
- unable to complete follow up in 2 and 30 days
- previously enrolled in this study (during a prior ED visit)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Thomas Jefferson Universitylead
- Northwestern Universitycollaborator
- Washington University School of Medicinecollaborator
Study Sites (1)
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
Related Publications (1)
McCarthy DM, Malone S, Papanagnou D, Leiby BE, Doty AMB, Watts P, Yadav R, Pugliese JK, Woodworth J, Camacho TE, Kean E, Rising KL. Targeted EHR-based communication of diagnostic uncertainty (TECU) in the emergency department: Protocol for an effectiveness implementation trial. Contemp Clin Trials. 2025 Jun;153:107910. doi: 10.1016/j.cct.2025.107910. Epub 2025 Apr 7.
PMID: 40204252DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Kristin L Rising, MD, MS
Thomas Jefferson University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2024
First Posted
October 15, 2024
Study Start
November 5, 2024
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
July 1, 2027
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share